Fetal adrenal development: Insight gained from adrenal tumors

Trends in Endocrinology and Metabolism

Volumn 16, Issue 5, 2005, Pages 235-242

  Coulter, Catherine L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; GROWTH FACTOR; SOMATOMEDIN B;

ADRENAL CANCER; ADRENAL CORTEX; ADRENAL CORTEX TUMOR; ADRENAL FUNCTION; ADRENAL GLAND; ADRENAL TUMOR; ANGIOGENESIS; APOPTOSIS; BRAIN DEVELOPMENT; CANCER GROWTH; CELL CYCLE; CELL DEATH; CHROMOSOME; DEVELOPMENT; FETUS DEVELOPMENT; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; ZONATION;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADULT; APOPTOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; PREGNANCY; SOMATOMEDINS;

EID: 20744447381     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2005.05.010     Document Type: Review

References (78)

1. S. Mesiano, and R.B. Jaffe Developmental and functional biology of the primate fetal adrenal cortex Endocr. Rev. 18 1997 378 403
2. C.L. Coulter Functional biology of the primate fetal adrenal gland: advances in technology provide new insight Clin. Exp. Pharmacol. Physiol. 31 2004 475 484
3. R. Voutilainen, and W.L. Miller Developmental and hormonal regulation of mRNAs for insulin-like growth factor II and steroidogenic enzymes in human fetal adrenals and gonads DNA 7 1988 9 15
4. N. Boulle Fibroblast growth factor-2 inhibits the maturation of pro-insulin-like growth factor-II (Pro-IGF-II) and the expression of insulin-like growth factor binding protein-2 (IGFBP-2) in the human adrenocortical tumor cell line NCI-H295R Endocrinology 141 2000 3127 3136
5. J. Liu H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells J. Clin. Endocrinol. Metab. 80 1995 492 496
6. J. Liu Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells J. Clin. Endocrinol. Metab. 82 1997 1766 1771
7. F. de Fraipont Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy J. Clin. Endocrinol. Metab. 90 2005 1819 1829
8. I. Bourdeau Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators Oncogene 23 2004 1575 1585
9. V. Ilvesmaki Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas J. Clin. Endocrinol. Metab. 77 1993 852 858
10. V. Ilvesmaki Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas Horm. Metab. Res. 30 1998 619 623
11. A. Logie Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line J. Mol. Endocrinol. 23 1999 23 32
12. N. Boulle Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors J. Clin. Endocrinol. Metab. 83 1998 1713 1720
13. M.M. Weber Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands Eur. J. Endocrinol. 136 1997 296 303
14. S. Leboulleux Loss of heterozygosity at the mannose 6-phosphate/insulin- like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis Eur. J. Endocrinol. 144 2001 163 168
15. W.E. Rainey The adrenal genetic puzzle: how do the fetal and adult pieces differ? Endocr. Res. 28 2002 611 622
16. G.W. Aberdeen Developmental expression of and effect of betamethasone on the messenger ribonucleic acid levels for peptide growth factors in the baboon fetal adrenal gland J. Endocrinol. 163 1999 123 130
17. C.L. Coulter Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation Endocrinology 137 1996 4487 4498
18. T.J. Giordano Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis Am. J. Pathol. 162 2003 521 531
19. W.E. Rainey Gene profiling of human fetal and adult adrenals J. Endocrinol. 171 2001 209 215
20. D.S. Franklin Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity Mol. Cell. Biol. 20 2000 6147 6158
21. F. Wilkin Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression J. Clin. Endocrinol. Metab. 85 2000 2048 2056
22. A. Murrell An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype Hum. Mol. Genet. 13 2004 247 255
23. V. Grandjean Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome Proc. Natl. Acad. Sci. U. S. A. 97 2000 5279 5284
24. N. Diaz-Meyer Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome J. Med. Genet. 40 2003 797 801
25. R. Voutilainen Parallel regulation of parentally imprinted H19 and insulin-like growth factor-II genes in cultured human fetal adrenal cells Endocrinology 134 1994 2051 2056
26. Z.H. Gao Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors J. Clin. Endocrinol. Metab. 87 2002 1170 1176
27. R.C. Ribeiro, and B. Figueiredo Childhood adrenocortical tumours Eur. J. Cancer 40 2004 1117 1126
28. R.C. Ribeiro An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma Proc. Natl. Acad. Sci. U. S. A. 98 2001 9330 9335
29. C.A. Longui Inhibin α-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers J. Med. Genet. 41 2004 354 359
30. M. Cherian-Shaw Regulation of steroidogenesis by p53 in macaque granulosa cells and H295R human adrenocortical cells Endocrinology 145 2004 5734 5744
31. B.C. de Figueiredo Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors J. Clin. Endocrinol. Metab. 90 2005 615 619
32. G.P. Bernini Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues Br. J. Cancer 86 2002 1561 1565
33. J.L. Shifren Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells J. Clin. Endocrinol. Metab. 83 1998 1342 1347
34. E.D. Rabinovsky, and R. Draghia-Akli Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis Mol. Ther. 9 2004 46 55
35. C.R. Tait, and P.F. Jones Angiopoietins in tumours: the angiogenic switch J. Pathol. 204 2004 1 10
36. S. Bekaert Telomere biology in mammalian germ cells and during development Dev. Biol. 274 2004 15 30
37. B. Sun Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase Cancer Res. 64 2004 6144 6151
38. M. Thomas Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase Nat. Biotechnol. 18 2000 39 42
39. J. Lafont The expression of novH in adrenocortical cells is down-regulated by TGF β1 through c-Jun in a Smad-independent manner J. Biol. Chem. 277 2002 41220 41229
40. S. Kocialkowski Expression of the human NOV gene in first trimester fetal tissues Anat. Embryol. (Berl.) 203 2001 417 427
41. C. Martinerie Altered expression of novH is associated with human adrenocortical tumorigenesis J. Clin. Endocrinol. Metab. 86 2001 3929 3940
42. J. Ratcliffe Identification of definitive and fetal zone markers in the human fetal adrenal gland reveals putative developmental genes J. Clin. Endocrinol. Metab. 88 2003 3272 3277
43. F. Beuschlein Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis Horm. Metab. Res. 36 2004 392 396
44. T. Vanttinen Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis J. Endocrinol. 178 2003 479 489
45. T. Vanttinen Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells J. Clin. Endocrinol. Metab. 87 2002 4257 4263
46. M. Matzuk Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice Proc. Natl. Acad. Sci. U. S. A. 91 1994 8817 8821
47. J. Arola Expression of inhibin α in adrenocortical tumours reflects the hormonal status of the neoplasm J. Endocrinol. 165 2000 223 229
48. A. Lacroix Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome Endocr. Rev. 22 2001 75 110
49. A. Lacroix Cushing's syndrome variants secondary to aberrant hormone receptors Trends Endocrinol. Metab. 15 2004 375 382
50. K.L. Parker Steroidogenic factor 1: an essential mediator of endocrine development Recent Prog. Horm. Res. 57 2002 19 36
51. N.A. Rahman Adrenocortical tumorigenesis in transgenic mice expressing the inhibin α-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4 Mol. Endocrinol. 18 2004 2553 2569
52. A.S. Barbosa Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms BMC Endocr. Disord. 4 2004 3
53. S. Kiiveri Differential expression of GATA-4 and GATA-6 in fetal and adult mouse and human adrenal tissue Endocrinology 143 2002 3136 3143
54. S. Kiiveri Transcription factors GATA-4 and GATA-6 in human adrenocortical tumors Endocr. Res. 30 2004 919 923
55. K.J. Saner Steroid sulfotransferase (SULT2A1) gene transcription is regulated by steroidogenic factor 1 (SF1) and GATA-6 in the human adrenal Mol. Endocrinol. 19 2005 184 197
56. P. Jimenez GATA-6 is expressed in the human adrenal and regulates transcription of genes required for adrenal androgen biosynthesis Endocrinology 144 2003 4285 4288
57. N.A. Hanley Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation Mol. Endocrinol. 15 2001 57 68
58. E. Lalli, and P. Sassone-Corsi DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation Mol. Endocrinol. 17 2003 1445 1453
59. T. Suzuki Chicken ovalbumin upstream promoter transcription factor II in the human adrenal cortex and its disorders J. Clin. Endocrinol. Metab. 85 2000 2752 2757
60. H. Shibata Expression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesis Mol. Genet. Metab. 74 2001 206 216
61. H. Shibata Nuclear receptors and co-regulators in adrenal tumors Horm. Res. 59 Suppl. 1 2003 85 93
62. L. Lu Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders J. Clin. Endocrinol. Metab. 89 2004 4113 4118
63. M.H. Bassett The orphan nuclear receptor NGFIB regulates transcription of 3β-hydroxysteroid dehydrogenase. Implications for the control of adrenal functional zonation J. Biol. Chem. 279 2004 37622 37630
64. M.H. Bassett The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production Mol. Endocrinol. 18 2004 279 290
65. D. Rosenberg Transcription factor 3′,5′-cyclic adenosine 5′-monophosphate-responsive element-binding protein (CREB) is decreased during human adrenal cortex tumorigenesis and fetal development J. Clin. Endocrinol. Metab. 88 2003 3958 3965
66. A.M. Lefrancois-Martinez Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors J. Clin. Endocrinol. Metab. 89 2004 3010 3019
67. G. Watanabe Angiotensin II activation of cyclin D1-dependent kinase activity J. Biol. Chem. 271 1996 22570 22577
68. F. Tissier Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors Eur. J. Endocrinol. 150 2004 809 817
69. N. Bourcigaux High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors J. Clin. Endocrinol. Metab. 85 2000 322 330
70. W. Bonfig Virilising adrenocortical tumours in children Eur. J. Pediatr. 162 2003 623 628
71. G.N. Thomopoulos Immunocytochemical localization of NOVH protein and ultrastructural characteristics of NCI-H295R cells J. Submicrosc. Cytol. Pathol. 33 2001 251 260
72. Y. Hirano Telomerase activity as an indicator of potentially malignant adrenal tumors Cancer 83 1998 772 776
73. L. Yang Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells Mech. Ageing Dev. 122 2001 1685 1694
74. K.S. Rehman Profiling the steroidogenic pathway in human fetal and adult adrenals J. Soc. Gynecol. Investig. 10 2003 372 380
75. W.A. Freije Expression of 11 β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) in the human fetal adrenal J. Soc. Gynecol. Investig. 4 1997 305 309
76. U. Enberg Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2 Eur. J. Endocrinol. 151 2004 73 85
77. C.L. Coulter Expression of 11β-hydroxysteroid dehydrogenase type 2 (11βHSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma Mol. Cell. Endocrinol. 154 1999 71 77
78. D. Rosenberg cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors Endocr. Res. 28 2002 765 775